Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 150 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Rita B.

Belgium

USD 150 /hr

Health Economist, Data Analyst, HTA, Systematic Review and Meta-Analysis, Publications Support | 12+ years of experience

Profile Summary

A health economist with 12+ years of expertise in academia and industry worldwide. Business strategist. Expert in economic modelling and prediction models, cost-effectiveness analyses, HEOR projects, health technology assessments, the use of real world evidence data, global value dossiers and regulatory affairs, systematic reviews and meta-analyses. Hands-on experience with advanced data science methods. I have experience in creating comprehensive and impactful solutions to support market access for innovations for global clients.

Subject Matter Expertise

• ☆ Data Analysis
• ☆ Predictive Modeling & Analytics
• ☆ Data Collection
• ☆ Statistics
• ☆ Meta-Analysis
• ☆ Medical Statistics
• ☆ Health Data Analysis
• ☆ Trend Analysis
• ☆ Health Policy
• ☆ Economic Policy
• ☆ Drug Development
• ☆ Pharmaceutical Regulatory Affairs
• ☆ Clinical Trials
• ☆ Health Technology Assessment
• ☆ Regulatory Affairs
• ☆ Literature Review
• ☆ Systematic Literature Review
• ☆ Health Economics

Services

• Writing
• Research
• Consulting
• Data & AI

Writing Technical Writing, Newswriting

Research Market Research, User Research, Meta-Research, Feasibility Study, Fact Checking, Gap Analysis, Systematic Literature Review, Secondary Data Collection

Consulting Regulatory Consulting

Data & AI Predictive Modeling, Statistical Analysis, Big Data Analytics, Data Insights

Work Experience

Founder and Lead Scientist

Oraculum Healthcare Consultancy

February 2021 - Present

Postdoctoral Fellow

Houston Methodist Research Institute

August 2018 - Present

Associate Researcher

University of Liege, Belgium

April 2015 - June 2018

Visiting Postdoctoral Researcher

Houston Methodist Research Institute

January 2015 - March 2015

Postdoctoral Researcher

Hasselt University

October 2012 - March 2015

Visiting Postdoctoral Researcher

Texas Children's Hospital

January 2014 - March 2014

Doctoral Researcher and Graduate Teaching Assistant

Hasselt University

November 2007 - March 2012

Visiting Doctoral Researcher

University of Texas Health Science Center at Houston

October 2008 - December 2008

Education

PhD (Applied Economics)

Universiteit Hasselt

November 2007 - March 2012

Masters of Science

Hasselt University

September 2005 - July 2007

Bachelor of Science

Hasselt University

September 2001 - September 2004

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Nima Ahmadi and Farzan Sasangohar and Tariq Nisar and Valerie Danesh and Ethan Larsen and Ineen Sultana and Rita Bosetti(2022). Quantifying Occupational Stress in Intensive Care Unit Nurses: An Applied Naturalistic Study of Correlations Among Stress, Heart Rate, Electrodermal Activity, and Skin Temperature . Human Factors: The Journal of the Human Factors and Ergonomics Society. 64. (1). p. 159--172. {SAGE} Publications

Rita Bosetti and Laila Tabatabai and Georges Naufal and Terri Menser and Bita Kash(2021). Comprehensive cost-effectiveness of diabetes management for the underserved in the United States: A systematic review . PLOS ONE. 16. (11). p. e0260139. Public Library of Science ({PLoS})

Basem G. Soliman and Nabil Tariq and Yi Ying Law and Stephanie Yi and Nwabunie Nwana and Rita Bosetti and Bita Kash and Linda W. Moore and A. Osama Gaber and Vadim Sherman(2021). Effectiveness of Bariatric Surgery in Increasing Kidney Transplant Eligibility in Patients with Kidney Failure Requiring Dialysis . Obesity Surgery. Springer Science and Business Media {LLC}

Rita Bosetti and Laila Tabatabai and George Naufal and Rosbel Brito and Bita Kash(2020). New model of integrated care for uncontrolled type 2 diabetes in a retrospective, underserved adult population in the USA: a study protocol for an effectiveness and cost-effectiveness analysis . BMJ Open. 10. (7). p. e038084. {BMJ}

Rita Bosetti and Stephen L Jones(2019). Cost–effectiveness of nanomedicine: estimating the real size of nano-costs . Nanomedicine. 14. (11). p. 1367--1370. Future Medicine Ltd

Rita Bosetti(2015). Cost–effectiveness of nanomedicine: the path to a future successful and dominant market? . Nanomedicine. 10. (12). p. 1851--1853. Future Medicine Ltd

Rita Bosetti and Gabriella Ferrandina and Wim Marneffe and Giovanni Scambia and Lode Vereeck(2014). Cost–effectiveness of gemcitabine versus PEGylated liposomal doxorubicin for recurrent or progressive ovarian cancer: comparing chemotherapy with nanotherapy . Nanomedicine. 9. (14). p. 2175--2186. Future Medicine Ltd

Rita Bosetti and Wim Marneffe and Lode Vereeck(2013). Assessing the need for quality-adjusted cost–effectiveness studies of nanotechnological cancer therapies . Nanomedicine. 8. (3). p. 487--497. Future Medicine Ltd

Rita Bosetti and Lode Vereeck(2012). The impact of effective patents on future innovations in nanomedicine . Pharmaceutical Patent Analyst. 1. (1). p. 37--43. Future Science Ltd

Rita Bosetti and Lode Vereeck(2011). Future of nanomedicine: obstacles and remedies . Nanomedicine. 6. (4). p. 747--755. Future Medicine Ltd